chr11:49145092:> Detail (hg38)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr11:49,166,644-49,230,188 |
| hg38 | chr11:49,145,092-49,208,636 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.005 | Cardiovascular Diseases | NA | BeFree,GAD | Detail | |
| 0.002 | brain ischemia | NA | GAD | Detail | |
| 0.002 | Chromosome Aberrations | NA | GAD | Detail | |
| 0.002 | cleft lip | NA | GAD | Detail | |
| 0.002 | cleft palate | NA | GAD | Detail | |
| 0.001 | colorectal carcinoma | NA | BeFree | Detail | |
| 0.003 | Colorectal Neoplasms | NA | LHGDN | Detail | |
| 0.005 | Coronary heart disease | NA | GAD | Detail | |
| <0.001 | Mental Depression | NA | BeFree | Detail | |
| <0.001 | depressive disorder | NA | BeFree | Detail | |
| 0.002 | DNA Damage | NA | GAD | Detail | |
| 0.002 | Folic Acid Deficiency | NA | GAD | Detail | |
| <0.001 | glioblastoma | Overexpression and Nucleolar Localization of γ-Tubulin Small Complex Proteins GC... | BeFree | 26079448 | Detail |
| <0.001 | Herpes NOS | NA | BeFree | Detail | |
| 0.003 | Hypertensive disease | NA | BeFree,GAD | Detail | |
| 0.005 | Kidney Failure, Chronic | NA | GAD,LHGDN | Detail | |
| <0.001 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
| <0.001 | Chronic Obstructive Airway Disease | NA | BeFree | Detail | |
| 0.002 | Malignant neoplasm of stomach | NA | GAD | Detail | |
| <0.001 | measles | NA | BeFree | Detail | |
| <0.001 | multiple myeloma | NA | BeFree | Detail | |
| <0.001 | myocardial infarction | NA | BeFree | Detail | |
| 0.003 | Neoplasm Metastasis | NA | BeFree | Detail | |
| 0.005 | Neural Tube Defects | NA | GAD | Detail | |
| <0.001 | Peritonsillar Abscess | NA | BeFree | Detail | |
| 0.002 | Phenylketonurias | NA | GAD | Detail | |
| 0.129 | Prostatic Neoplasms | NA | BeFree,CTD_human,LHGDN | Detail | |
| <0.001 | retinoblastoma | NA | BeFree | Detail | |
| <0.001 | schizophrenia | NA | BeFree | Detail | |
| <0.001 | Staphylococcal Infections | NA | BeFree | Detail | |
| 0.003 | Cerebrovascular accident | NA | BeFree,GAD | Detail | |
| <0.001 | tetanus | NA | BeFree | Detail | |
| 0.002 | Tobacco use disorder | NA | GAD | Detail | |
| <0.001 | Virus Diseases | NA | BeFree | Detail | |
| 0.002 | Vitamin B Deficiency | NA | GAD | Detail | |
| 0.003 | spina bifida | NA | BeFree,GAD | Detail | |
| <0.001 | Depressive Symptoms | NA | BeFree | Detail | |
| <0.001 | Small cell carcinoma of lung | PSMA is expressed not only in NECs of NSCLC and SCLC but also in tumor cells of ... | BeFree | 25978404 | Detail |
| <0.001 | Secondary malignant neoplasm of bone | NA | BeFree | Detail | |
| 0.002 | Aortic Aneurysm, Abdominal | NA | GAD | Detail | |
| <0.001 | Tumor Progression | NA | BeFree | Detail | |
| <0.001 | Hereditary pancreatitis | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of lung | Expression of prostate-specific membrane antigen in lung cancer cells and tumor ... | BeFree | 25978404 | Detail |
| <0.001 | Prostate cancer recurrent | NA | BeFree | Detail | |
| 0.001 | Solid tumour | NA | BeFree | Detail | |
| 0.037 | Malignant neoplasm of prostate | We have identified several PSA-PSMA prostate clones during prostate cancer progr... | BeFree,GAD | 24788382 | Detail |
| 0.037 | Malignant neoplasm of prostate | A superior anti-cancer potential was attained with PSMA antibody conjugated PLGA... | BeFree,GAD | 25028336 | Detail |
| 0.037 | Malignant neoplasm of prostate | Another emerging strategy could be based on prostate specific membrane antigen (... | BeFree,GAD | 25469883 | Detail |
| 0.037 | Malignant neoplasm of prostate | In a recent report, we established a nanomicelle-based strategy to deliver p110β... | BeFree,GAD | 25620467 | Detail |
| 0.037 | Malignant neoplasm of prostate | Prostate-specific membrane antigen (PSMA) has been found in tumor neovasculature... | BeFree,GAD | 25978404 | Detail |
| <0.001 | Carcinogenesis | NA | BeFree | Detail | |
| 0.005 | hyperhomocysteinemia | NA | BeFree,GAD | Detail | |
| 0.033 | prostate carcinoma | We have identified several PSA-PSMA prostate clones during prostate cancer progr... | BeFree | 24788382 | Detail |
| 0.033 | prostate carcinoma | A superior anti-cancer potential was attained with PSMA antibody conjugated PLGA... | BeFree | 25028336 | Detail |
| 0.033 | prostate carcinoma | Another emerging strategy could be based on prostate specific membrane antigen (... | BeFree | 25469883 | Detail |
| 0.033 | prostate carcinoma | In a recent report, we established a nanomicelle-based strategy to deliver p110β... | BeFree | 25620467 | Detail |
| 0.033 | prostate carcinoma | Prostate-specific membrane antigen (PSMA) has been found in tumor neovasculature... | BeFree | 25978404 | Detail |
| <0.001 | breast carcinoma | NA | BeFree | Detail | |
| <0.001 | Carcinoma of lung | Expression of prostate-specific membrane antigen in lung cancer cells and tumor ... | BeFree | 25978404 | Detail |
| <0.001 | Malignant neoplasm of kidney | NA | BeFree | Detail | |
| <0.001 | Precursor Cell Lymphoblastic Leukemia Lymphoma | Children with ALL (n = 96) were screened for GCPII C1561T, RFC1 G80A, cSHMT C142... | BeFree | 22838948 | Detail |
| 0.001 | Metastatic Prostate Carcinoma | NA | BeFree | Detail | |
| <0.001 | Acute lymphocytic leukemia | Children with ALL (n = 96) were screened for GCPII C1561T, RFC1 G80A, cSHMT C142... | BeFree | 22838948 | Detail |
| <0.001 | Hormone refractory prostate cancer | NA | BeFree | Detail | |
| <0.001 | renal carcinoma | NA | BeFree | Detail | |
| <0.001 | Salivary Gland Pleomorphic Adenoma | NA | BeFree | Detail | |
| 0.003 | Tumor-Associated Vasculature | Expression of prostate-specific membrane antigen in lung cancer cells and tumor ... | BeFree | 25978404 | Detail |
| 0.008 | colorectal cancer | NA | BeFree,GAD | Detail | |
| 0.001 | Benign Prostatic Hyperplasia | NA | BeFree | Detail | |
| <0.001 | prostatic hypertrophy | NA | BeFree | Detail | |
| <0.001 | coronary artery disease | NA | BeFree | Detail | |
| <0.001 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree | Detail | |
| <0.001 | Homocysteinemia | NA | BeFree | Detail | |
| 0.002 | Hyperhomocystinemia | NA | GAD | Detail | |
| <0.001 | Complete obstruction | NA | BeFree | Detail | |
| 0.004 | adenocarcinoma | NA | BeFree,LHGDN | Detail | |
| <0.001 | Anxiety Disorders | NA | BeFree | Detail | |
| <0.001 | Astrocytoma | The expression, cellular distribution, and subcellular sorting of the microtubul... | BeFree | 26079448 | Detail |
| <0.001 | Malignant neoplasm of breast | NA | BeFree | Detail | |
| 0.001 | Adenocarcinoma of prostate | NA | BeFree | Detail | |
| <0.001 | Non-small cell lung carcinoma | The presence of PSMA (+) tumor cells and PSMA (+) NECs in NSCLC was negatively c... | BeFree | 25978404 | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Overexpression and Nucleolar Localization of γ-Tubulin Small Complex Proteins GCP2 and GCP3 in Gliob... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| PSMA is expressed not only in NECs of NSCLC and SCLC but also in tumor cells of most NSCLC patients. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Expression of prostate-specific membrane antigen in lung cancer cells and tumor neovasculature endot... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We have identified several PSA-PSMA prostate clones during prostate cancer progression. | DisGeNET | Detail |
| A superior anti-cancer potential was attained with PSMA antibody conjugated PLGA-CUR NPs in prostate... | DisGeNET | Detail |
| Another emerging strategy could be based on prostate specific membrane antigen (PSMA), a unique memb... | DisGeNET | Detail |
| In a recent report, we established a nanomicelle-based strategy to deliver p110β-specific inhibitor ... | DisGeNET | Detail |
| Prostate-specific membrane antigen (PSMA) has been found in tumor neovasculature endothelial cells (... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We have identified several PSA-PSMA prostate clones during prostate cancer progression. | DisGeNET | Detail |
| A superior anti-cancer potential was attained with PSMA antibody conjugated PLGA-CUR NPs in prostate... | DisGeNET | Detail |
| Another emerging strategy could be based on prostate specific membrane antigen (PSMA), a unique memb... | DisGeNET | Detail |
| In a recent report, we established a nanomicelle-based strategy to deliver p110β-specific inhibitor ... | DisGeNET | Detail |
| Prostate-specific membrane antigen (PSMA) has been found in tumor neovasculature endothelial cells (... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Expression of prostate-specific membrane antigen in lung cancer cells and tumor neovasculature endot... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Children with ALL (n = 96) were screened for GCPII C1561T, RFC1 G80A, cSHMT C1420T, TYMS 5´-UTR 2R3R... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Children with ALL (n = 96) were screened for GCPII C1561T, RFC1 G80A, cSHMT C1420T, TYMS 5´-UTR 2R3R... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Expression of prostate-specific membrane antigen in lung cancer cells and tumor neovasculature endot... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The expression, cellular distribution, and subcellular sorting of the microtubule (MT)-nucleating γ-... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The presence of PSMA (+) tumor cells and PSMA (+) NECs in NSCLC was negatively correlated with age a... | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs386514057 dbSNP
- Genome
- hg38
- Position
- chr11:49,145,092-49,208,636
- Variant Type
- snv
Genome browser